News from the healthcare data industry
Posted 16 May 2022 | By Mary Ellen Schneider Sara Head, PhD, FDA Office of Women’s HealthThe US Food and Drug Administration (FDA) is working on ways to facilitate greater use...
Only about half of a select group of clinical trials could be well-emulated with available real world evidence, according to the newly discussed results of an FDA pilot program. The...
Anthem partnered with Google Cloud to create a synthetic data platform that can train AI algorithms to identify fraudulent claims and abnormalities in patients’ health, The Wall Street Journal reported May 17. ...
May 12, 2022 Michael J. Howley, PA-C, MBA, PhD , Peter Malamis, MBA Survey among pharma and CRO executives evaluates current usage of RWD. Real-world data is enjoying prominence after how well...
The EU plan to harmonise electronic health data promises to make life easier for start-ups, but barriers to success still remain By Ian Mundell Proposals to build a European Health Data...
As life science organizations continue to leverage both real world data [RWD] and real-world evidence [RWE] in the product approval landscape, a more nuanced understanding of both RWD and RWE...
Today, the European Commission launched the European Health Data Space (EHDS), one of the central building blocks of a strong European Health Union. The EHDS will help the EU to...
Sucharita Mistry, PhD Real-world data confirm that there is no standard approach for treating patients with triple-class-exposed relapsed/refractory multiple myeloma (RRMM), and these patients continue to have poor outcomes. Researchers...
The Framework aims to assist stakeholders with use of new, innovative, and existing statistical methods for evidence fusion from data external to a clinical study. April 28, 2022 11:23 AM...
Synthetic datasets could change the way developers train AI models in healthcare. They have the potential to increase the size of training datasets for AI models, whilst protecting patient privacy,...